` Comparison: 23E2, ABT - Alpha Spread

23E2
vs
ABT

Over the past 12 months, Ekso Bionics Holdings Inc has underperformed ABT, delivering a return of -75% compared to the ABT's +20% growth.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
23E2
ABT
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

Intrinsic Value
11.877 EUR
Undervaluation 72%
Intrinsic Value
Price
ABT Intrinsic Value
111.42 USD
Overvaluation 15%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Ekso Bionics Holdings Inc
F:23E2
3.315 EUR
Abbott Laboratories
NYSE:ABT
131.02 USD
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
23E2, ABT

23E2
ABT
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Ekso Bionics Holdings Inc
Revenue
Abbott Laboratories
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
23E2, ABT

23E2
ABT
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Ekso Bionics Holdings Inc
F:23E2
Abbott Laboratories
NYSE:ABT
What is Free Cash Flow?

Gross Margin

Ekso Bionics Holdings Inc
51.5%
ABT
56.2%

Operating Margin

Ekso Bionics Holdings Inc
-82.6%
ABT
17.9%

Net Margin

Ekso Bionics Holdings Inc
-77.2%
ABT
32.4%

FCF Margin

Ekso Bionics Holdings Inc
-62.8%
ABT
15.4%

ROE

Ekso Bionics Holdings Inc
-98.4%
ABT
31.7%

ROA

Ekso Bionics Holdings Inc
-45.1%
ABT
18.1%

ROIC

Ekso Bionics Holdings Inc
-68.3%
ABT
20.6%

ROCE

Ekso Bionics Holdings Inc
-67.8%
ABT
12.1%

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
23E2, ABT

Loading

Performance Gap
23E2, ABT

Loading
23E2
ABT
Difference
www.alphaspread.com

Performance By Year
23E2, ABT

Loading
23E2
ABT
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 23E2 to other stocks
Unlock Full Access to Alpha Spread
Create Free Account